I hear you Kenbe. We're each going to deal with this in our own way and I can't dispute anyone's feelings or opinions. As for me, I see a turnaround with everything else going on. March's revenue totals will be an indicator for the direction of compounding of which I maintain will be a significant contributor to the revenues. And I see PIMD and the Diabetes programs increasing their impact to the bottom line as well.